Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.
Hsu HC, Thiam TK, Lu YJ, Yeh CY, Tsai WS, You JF, Hung HY, Tsai CN, Hsu A, Chen HC, Chen SJ, Yang TS.
Hsu HC, et al. Among authors: tsai ws, tsai cn.
Oncotarget. 2016 Apr 19;7(16):22257-70. doi: 10.18632/oncotarget.8076.
Oncotarget. 2016.
PMID: 26989027
Free PMC article.